Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Hair salons offer more than a trim: HIV prevention and birth control on offer

NCT ID NCT04222504

Prevention Sponsor: Massachusetts General Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tested whether offering sexual health services like HIV prevention pills (PrEP), STI testing, and birth control in hair salons could reach women who might not visit a clinic. About 436 women in Umlazi, South Africa, took part. Some salons offered these services, while a control salon did not. The goal was to see if women would use the services and come back for follow-up visits.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
PrEP (tenofovir/emtricitabine), hormonal birth control (oral, injectable), STI testing
What this could lead to
If successful, this approach could make it easier for women to access HIV prevention and family planning in familiar, convenient places like hair salons.
What could go wrong
This is a small pilot study, so results may not apply to other communities. It only measures whether women choose to use the services, not long-term health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

436 people

The number who actually took part.

Started

Feb 2021

Finished

Mar 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Female * 18 years or older * English or Zulu speaking * Able and willing to consent Exclusion Criteria: * Symptoms of acute HIV viral syndrome * Known pregnancy at baseline

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Contraceptive usage are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Contraception Behavior sexually transmitted disease HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contraceptive usage Pre-exposure prophylaxis STI

Contacts and locations

Locations

  • Adrenergy Research Innovations

    Durban, South Africa

More trials for these conditions

Other studies related to the condition(s) this trial covers.